Form 15-12G GAN Ltd
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-39274
GAN Limited
(Exact name of registrant as specified in its charter)
10845 Griffith Peak Drive, Suite 200
Las Vegas, Nevada 89135
(833) 565-0550
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary Shares, $0.01 par value per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | ☒ | |
| Rule 12g-4(a)(2) | ☐ | |
| Rule 12h-3(b)(1)(i) | ☒ | |
| Rule 12h-3(b)(1)(ii) | ☐ | |
| Rule 15d-6 | ☐ | |
| Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: One (1) holder
Pursuant to the requirements of the Securities Exchange Act of 1934, GAN Limited has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: June 9, 2025 | GAN Limited | |
| By: | /s/
Seamus McGill
| |
| Name: | Seamus McGill | |
| Title: | Chief Executive Officer | |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gain Therapeutics updates rexaceract trial data, plans Phase 2 start
- Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film
- GaN Charger Manufacturer Wecent Introduces 100W Travel Adapter with Global Plug Versatility
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share